- Home
- AVIR vs SSP Comparison
AVIR vs SSP Comparison
Compare AVIR & SSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- SSP
- Stock Information
- Founded
- AVIR 2012
- SSP 1878
- Country
- AVIR United States
- SSP United States
- Employees
- AVIR N/A
- SSP N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- SSP Broadcasting
- Sector
- AVIR Health Care
- SSP Industrials
- Exchange
- AVIR Nasdaq
- SSP Nasdaq
- Market Cap
- AVIR 273.0M
- SSP 252.6M
- IPO Year
- AVIR 2020
- SSP 1988
- Fundamental
- Price
- AVIR $3.90
- SSP $3.33
- Analyst Decision
- AVIR Hold
- SSP Buy
- Analyst Count
- AVIR 1
- SSP 2
- Target Price
- AVIR $6.00
- SSP $6.00
- AVG Volume (30 Days)
- AVIR 426.9K
- SSP 855.0K
- Earning Date
- AVIR 08-06-2025
- SSP 08-07-2025
- Dividend Yield
- AVIR N/A
- SSP N/A
- EPS Growth
- AVIR N/A
- SSP N/A
- EPS
- AVIR N/A
- SSP 0.93
- Revenue
- AVIR N/A
- SSP $2,472,701,000.00
- Revenue This Year
- AVIR N/A
- SSP N/A
- Revenue Next Year
- AVIR N/A
- SSP $9.60
- P/E Ratio
- AVIR N/A
- SSP $3.58
- Revenue Growth
- AVIR N/A
- SSP 6.28
- 52 Week Low
- AVIR $2.46
- SSP $1.36
- 52 Week High
- AVIR $4.15
- SSP $4.17
- Technical
- Relative Strength Index (RSI)
- AVIR 67.66
- SSP 53.36
- Support Level
- AVIR $3.36
- SSP $3.05
- Resistance Level
- AVIR $3.53
- SSP $3.41
- Average True Range (ATR)
- AVIR 0.15
- SSP 0.27
- MACD
- AVIR -0.00
- SSP -0.06
- Stochastic Oscillator
- AVIR 97.24
- SSP 25.00
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About SSP E.W. Scripps Company (The)
The E W Scripps Co is a media enterprise with interests in local and national media brands. It owns and operates a collection of daily and community newspapers in medium-sized cities in the southern and western portions of the United States. The company's operating segment includes Local Media, Scripps Networks, and Other. It generates maximum revenue from the Local Media segment. The Local Media segment includes local broadcast stations and their related digital operations.